HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies.

AuthorsMónica Martín-Salces, Víctor Jiménez-Yuste, María Teresa Álvarez-Román, Isabel Rivas-Pollmar, Ana Rodríguez de la Rúa
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 108 Issue 4 Pg. 796-8 (Oct 2012) ISSN: 2567-689X [Electronic] Germany
PMID22836221 (Publication Type: Case Reports, Letter)
Chemical References
  • Antifibrinolytic Agents
  • Isoantibodies
  • von Willebrand Factor
  • Tranexamic Acid
  • F8 protein, human
  • Factor VIII
Topics
  • Adult
  • Antifibrinolytic Agents (administration & dosage)
  • Blood Transfusion
  • Cesarean Section
  • Factor VIII (administration & dosage)
  • Female
  • Humans
  • Infant, Newborn
  • Isoantibodies (blood)
  • Pregnancy
  • Pregnancy Complications, Hematologic (blood, immunology, therapy)
  • Tranexamic Acid (administration & dosage)
  • Uterine Hemorrhage (etiology, therapy)
  • von Willebrand Disease, Type 3 (blood, complications, immunology, therapy)
  • von Willebrand Factor (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: